| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.138 | 7.260 | 7.039 | 7.487 | 7.991 | 30.331 | 9.183 |
| Total Income - EUR | - | - | - | 3.138 | 7.260 | 7.039 | 7.487 | 7.991 | 30.331 | 9.183 |
| Total Expenses - EUR | - | - | - | 491 | 116 | 102 | 124 | 2.088 | 3.216 | 4.184 |
| Gross Profit/Loss - EUR | - | - | - | 2.646 | 7.144 | 6.937 | 7.364 | 5.903 | 27.114 | 5.000 |
| Net Profit/Loss - EUR | - | - | - | 2.552 | 6.926 | 6.742 | 7.166 | 5.668 | 22.636 | 3.929 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Egmont Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.653 | 7.068 | 8.429 | 11.497 | 6.587 | 26.184 | 4.231 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 167 | 0 |
| Receivables | - | - | - | 0 | 5.461 | 0 | 0 | 6.499 | 2.931 | 3.213 |
| Cash | - | - | - | 2.653 | 1.607 | 8.429 | 11.497 | 88 | 23.085 | 1.018 |
| Shareholders Funds | - | - | - | 2.595 | 6.977 | 8.337 | 11.440 | 6.528 | 22.684 | 3.977 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 58 | 91 | 92 | 58 | 59 | 3.499 | 254 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Egmont Medical S.r.l.